SEEMA S AHUJA
Medical Practice in San Antonio, TX
License number
Pennsylvania MD041043L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
San Antonio, TX 78240
Pennsylvania
Pennsylvania
Personal information
See more information about SEEMA S AHUJA at radaris.comName
Address
Phone
16503 Pembranch, San Antonio, TX 78240
1840 Autumn Leaf Ln, Huntingdon Valley, PA 19006
1840 Autumn Leaf Ln, Huntingdon Vy, PA 19006
10419 Early Square Ct, Houston, TX 77070
11102 Readvill Ln, Austin, TX 78739
Professional information
Dr. Seema S Ahuja - MD (Doctor of Medicine)
Hospitals:
7703 Floyd Curl Dr, San Antonio 78229
University Health System
4502 Medical Dr, San Antonio 78229
7703 Floyd Curl Dr, San Antonio 78229
University Health System
4502 Medical Dr, San Antonio 78229
University Health System
4502 Medical Dr, San Antonio 78229
7703 Floyd Curl Dr, San Antonio 78229
University Health System
4502 Medical Dr, San Antonio 78229
Education:
Medical Schools
Armed Forces Medical College, Maharashtra University Of Health Sciences
Graduated: 1983
Armed Forces Medical College, Maharashtra University Of Health Sciences
Graduated: 1983
Methods Of Reducing Bone Loss With Cd40 Ligand
US Patent:
6482411, Nov 19, 2002
Filed:
Aug 24, 2000
Appl. No.:
09/645926
Inventors:
Seema A. Ahuja - San Antonio TX
Lynda F. Bonewald - San Antonio TX
Lynda F. Bonewald - San Antonio TX
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
A61K 3817
US Classification:
4241851, 424 851, 4241841, 4241921, 4241781, 514 2, 514 8, 514 12, 514885, 530350, 530351
Abstract:
Provided are methods and compositions using one or more CD40 agonists, such as CD40 ligands and/or agonistic anti-CD40 antibodies, to reduce or prevent cell death, or apoptosis, in bone cells. Methods of treating or preventing bone loss, including osteoporosis, as well as methods of reducing or eliminating the bone loss associated with steroid administration are particularly provided. Further disclosed are a variety of therapeutic kits and cocktails.
Dc-Sign Isoforms, Related Compositions And Methods For Their Use In Disease Therapy
US Patent:
2005022, Oct 6, 2005
Filed:
May 5, 2003
Appl. No.:
10/513082
Inventors:
Sunil Ahuja - San Antonio TX, US
Seema Ahuja - San Antonio TX, US
Srinivas Mummidi - San Antonio TX, US
Gabriel Catano - San Antonio TX, US
Seema Ahuja - San Antonio TX, US
Srinivas Mummidi - San Antonio TX, US
Gabriel Catano - San Antonio TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
International Classification:
C12Q001/70, C07H021/04, C12N015/09, C07K014/705
US Classification:
435005000, 435069100, 435320100, 435325000, 530350000, 536023500
Abstract:
The present invention provides polypeptides of DC-SIGN 1, DC-SIGN2 and DC-SIGN3 isoforms, nucleic acids encoding these polypeptides, and methods of use in treating disease and modulating immune responses.
Cd40 Ligand And Cd40 Agonist Compositions And Methods Of Use
US Patent:
2003009, May 29, 2003
Filed:
Sep 12, 2002
Appl. No.:
10/242212
Inventors:
Seema Ahuja - San Antonio TX, US
Lynda Bonewald - San Antonio TX, US
Lynda Bonewald - San Antonio TX, US
Assignee:
Board of Regents, The University of Texas System
International Classification:
A61K039/395, A61K038/17
US Classification:
424/144100, 514/012000
Abstract:
Provided are methods and compositions using one or more CD40 agonists, such as CD40 ligands and/or agonistic anti-CD40 antibodies, to reduce or prevent cell death, or apoptosis, in bone cells. Methods of treating or preventing bone loss, including osteoporosis, as well as methods of reducing or eliminating the bone loss associated with steroid administration are particularly provided. Further disclosed are a variety of therapeutic kits and cocktails.